Validation of Vancomycin Dosing Guidance During Transition of Care

Area of Science:

• Pharmacology
• Infectious Diseases
• Clinical Pharmacy

Background:

• Vancomycin is crucial for treating serious gram-positive infections.
• Transitioning patients from intermittent to continuous vancomycin infusion for outpatient therapy poses a risk of suboptimal drug levels.
• Achieving therapeutic vancomycin targets is essential for effective treatment outcomes.

Purpose of the Study:

• To evaluate a model-based dosing algorithm for optimizing vancomycin therapy during care transitions.
• To assess the algorithm's performance in achieving target vancomycin concentrations within 7 days of switching infusion methods.

Main Methods:

• Utilized a published population pharmacokinetic model to guide vancomycin dosing.
• Employed demographic variables (age, weight, creatinine clearance) for initial dose calculations.
• Compared outcomes of patients receiving model-guided dosing against historic controls managed by clinicians alone.

Main Results:

• The model-based dosing approach significantly improved the proportion of patients achieving the target vancomycin steady-state concentration of 20-25 mg/L by day 7 (70.6% vs. 31.6%, P = .04).
• This demonstrates enhanced efficacy in reaching therapeutic vancomycin levels during the transition of care.

Conclusions:

• A model-based dosing algorithm effectively guides customized vancomycin dosing for patients transitioning from intermittent to continuous infusion.
• This strategy facilitates achievement of therapeutic targets, improving patient care during transitions.
• Further validation in larger patient cohorts is recommended to confirm these findings.